1133P Only early adjuvant radiotherapy, particularly of the tumor bed rather than the lymph node region, improves prognosis in Merkel cell carcinoma: Results from the prospective German MCC registry
Jürgen C. Becker(Düsseldorf University Hospital), Georg Lodde(Essen University Hospital), Ingrid Wolf(Medical University of Graz), Rudolf Herbst(Helios Klinikum Erfurt), Anja Gesierich(University of Michigan), Claas Ulrich(Charité - Universitätsmedizin Berlin), P. Mohr(Hochschule 21), Claudia Pfoehler(MSH Medical School Hamburg – University of Applied Sciences and Medical University), Wolfgang Galetzka(Institut für Medizinische Informatik, Biometrie und Epidemiologie), S. Ugurel-Becker(Ruhrlandklinik), Katharina C. Kähler(Christian-Albrechts-Universität zu Kiel), Friedegund Meier(National Center for Tumor Diseases), U. Leiter-Stoppke(University of Tübingen), Thilo Gambichler(Witten/Herdecke University), Frank Meiß(University of Freiburg), Jessica C. Hassel(German Cancer Research Center), Patrick Terheyden(University Hospital Schleswig-Holstein), Andreas Stang(Boston University), Christos C. Zouboulis(Freie Universität Berlin)
Cited by 0
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
|New England Journal of Medicine|2016|1.3k
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
|Journal of the European Academy of Dermatology and Venereology|2015|1.1k